Location History:
- Sequedin, FR (2009 - 2018)
- Equedin, FR (2016 - 2019)
Company Filing History:
10 out of 85 
2 out of 1,744 
2 out of 280 
Years Active: 2009-2019
Title: Christine Gaucher: Innovator in Pharmaceutical Compositions
Introduction
Christine Gaucher is a prominent inventor based in Sequedin, France. She has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. Her work primarily focuses on innovative therapeutic compositions that address critical medical needs.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II." This invention relates to novel pharmaceutical compositions that include an active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II), along with an anticancer agent. The therapeutic applications of these compositions are aimed at improving cancer treatment outcomes. Another notable patent is "Use of ADCC-optimized antibodies for treating low-responder patients." This invention concerns the use of human or humanized chimeric monoclonal antibodies produced in selected cell lines. These antibodies exhibit high ADCC activity and significant secretion of cytokines and interleukins, specifically targeting underpopulations of weak-response patients with certain genetic polymorphisms.
Career Highlights
Christine has worked with esteemed organizations such as Laboratoire Français du Fractionnement et des Biotechnologies and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative medical solutions.
Collaborations
Throughout her career, Christine has collaborated with notable colleagues, including Christophe De Romeuf and Dominique Bourel. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Christine Gaucher's contributions to pharmaceutical innovations demonstrate her commitment to advancing medical science. Her patents reflect her expertise and dedication to improving patient outcomes through innovative therapies.